E-DRUG: ARV local production costs (4)
---------------------------------------------------------------------
Dear Werner,
I support Lembit, we should first assess quality of products and taxes imposed on APIs in countries. Also, WHO pre-qualified facilities could be assessed for the cost of production you are requesting that way we are sure of comparable data.
Abdul
Abdul Razak Al-Abdneger-Issifu MSc Clinical Trials, B.Pharm
Clinical Research Associate
Quintiles West Africa Ltd
Ghana
RAZAK A. ISSIFU" <abdneger@hotmail.com>